Mads Hald Andersen

Publikation

Publikationer pr. år 2009 2009 2010 2011 2015 2016 2017 2018 2019 2019

• 70 Tidsskriftartikel
• 11 Review
• 5 Letter
• 4 Konferenceabstrakt i tidsskrift
• 8 Mere
  • 3 Kommentar/debat
  • 2 Leder
  • 2 Patent
  • 1 Doktordisputats

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2019

  Anti-cancer immunotherapy: breakthroughs and future strategies

  Andersen, M. H., 11 jan. 2019, I: Seminars in Immunopathology. 41, 1, s. 1-3 3 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  4 Citationer (Scopus)

• Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope

  Martinenaite, E., Ahmad, S. M., Bendtsen, S. K., Jørgensen, M. A., Weis-Banke, S. E., Svane, I. M. & Andersen, M. H., 2019, I: Cancer Immunology, Immunotherapy. 68, 11, s. 1901-1907 7 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Arginase 100%
  • T-Lymphocyte Epitopes 92%
  • Tumor Microenvironment 79%
  • Vaccination 61%
  • T-Lymphocytes 35%
  2 Citationer (Scopus)

• B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment

  Sørensen, A. L., Bjørn, M. E., Riley, C. H., Holmstrøm, M., Andersen, M. H., Svane, I. M., Mikkelsen, S. U., Skov, V., Kjaer, L., Hasselbalch, H. C. & Nielsen, C. H., 1 okt. 2019, I: European Journal of Haematology. s. 351-361 11 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • INCB018424 100%
  • Interferons 59%
  • B-Lymphocytes 49%
  • Phenotype 38%
  • Primary Myelofibrosis 26%
  5 Citationer (Scopus)

• Cancer immune therapy for lymphoid malignancies: recent advances

  Klausen, U., Jorgensen, N. G. D., Grauslund, J. H., Holmstrom, M. O. & Andersen, M. H., 11 jan. 2019, I: Seminars in Immunopathology. 41, 1, s. 111-124

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Bispecific Antibodies 100%
  • Active Immunotherapy 92%
  • Blocking Antibodies 85%
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma 69%
  • Immunotherapy 62%
  11 Citationer (Scopus)

• Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

  Hu, T., Buus, T. B., Krejsgaard, T., Nansen, A., Lundholt, B. K., Spee, P., Fredholm, S., Petersen, D. L., Blümel, E., Gluud, M., Monteiro, M. N., Willerslev-Olsen, A., Andersen, M. H., Straten, P. T., Met, Ö., Stolearenco, V., Fogh, H., Gniadecki, R., Nastasi, C., Litman, T., & 3 flereWoetmann, A., Gjerdrum, L. M. R. & Ødum, N., 1 aug. 2019, I: OncoTarget. 10, 47, s. 4894-4906 13 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • T-Lymphocytes 100%
  • Interleukin-9 58%
  • Voltage-Gated Potassium Channels 53%
  • Cytokine Receptors 48%
  • Annexin A5 45%
  1 Citationer (Scopus)

• High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

  Holmström, M. O., Ahmad, S. M., Klausen, U., Bendtsen, S. K., Martinenaite, E., Riley, C. H., Svane, I. M., Kjær, L., Skov, V., Ellervik, C., Pallisgaard, N., Hasselbalch, H. C. & Andersen, M. H., 2019, I: Blood Cancer Journal. 9, 2, 8.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Calreticulin 100%
  • Exons 59%
  • T-Lymphocytes 44%
  • Mutation 40%
  • Genes 28%
  14 Citationer (Scopus)

  47 Downloads (Pure)

• Immunoprofiles of colorectal cancer from Lynch syndrome

  Walkowska, J., Kallemose, T., Jönsson, G., Jönsson, M., Andersen, O., Andersen, M. H., Svane, I. M., Langkilde, A., Nilbert, M. & Therkildsen, C., 2 jan. 2019, I: OncoImmunology. 8, 1, 9 s., e1515612.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Hereditary Nonpolyposis Colorectal Neoplasms 100%
  • Colorectal Neoplasms 60%
  • beta 2-Microglobulin 34%
  • Ligands 29%
  • Neoplasms 24%
  2 Citationer (Scopus)

• MERTK Acts as a costimulatory receptor on human cd8 t cells

  Peeters, M. J. W., Dulkeviciute, D., Draghi, A., Ritter, C., Rahbech, A., Skadborg, S. K., Seremet, T., Simoes, A. M. C., Martinenaite, E., Halldorsdottir, H. R., Andersen, M. H., Olofsson, G. H., Svane, I. M., Rasmussen, L. J., Met, O., Becker, J. C., Donia, M., Desler, C. & Straten, P. T., 2019, I: Cancer Immunology Research. 7, 9, s. 1472-1484 13 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • c-Mer Tyrosine Kinase 100%
  • T-Lymphocytes 26%
  • Tumor-Infiltrating Lymphocytes 23%
  • Receptor Protein-Tyrosine Kinases 6%
  • Antigen-Presenting Cells 6%
  13 Citationer (Scopus)

• Neo-antigen specific memory T-cell responses in healthy individuals

  Holmström, M. O., Hasselbalch, H. C. & Andersen, M. H., 2019, I: OncoImmunology. 8, 7, 2 s., 1599640.

  Publikation: Bidrag til tidsskrift › Letter › peer review

  • Calreticulin 100%
  • Antigens 91%
  • T-Lymphocytes 88%
  • Mutation 80%
  • Exons 59%
  1 Citationer (Scopus)

• Peripheral memory T cells specific for Arginase-1

  Martinenaite, E., Ahmad, S. M., Svane, I. M. & Andersen, M. H., 2019, I: Cellular and Molecular Immunology. 16, 8, s. 718-719 2 s.

  Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

  3 Citationer (Scopus)

• Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

  Holmström, M. O., Novotny, G. W., Petersen, J., Aaboe-Jørgensen, M., Hasselbalch, H. C., Andersen, M. H., Nielsen, S. L., Fassi, D. E. & Schöllkopf, C., 10 nov. 2019, I: Leukemia and Lymphoma.

  Publikation: Bidrag til tidsskrift › Letter › peer review

  2 Citationer (Scopus)

• Staphylococcal alpha-toxin tilts the balance between malignant and non-malignant CD4+ T cells in cutaneous T-cell lymphoma

  Blümel, E., Willerslev-Olsen, A., Gluud, M., Lindahl, L. M., Fredholm, S., Nastasi, C., Krejsgaard, T., Surewaard, B. G. J., Koralov, S. B., Hu, T., Persson, J. L., Bonefeld, C. M., Geisler, C., Iversen, L., Becker, J. C., Andersen, M. H., Woetmann, A., Buus, T. B. & Ødum, N., 2 nov. 2019, I: OncoImmunology. 8, 11, 7 s., e1641387.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • staphylococcal alpha-toxin 100%
  • Cutaneous T-Cell Lymphoma 79%
  • T-Lymphocytes 37%
  • Disease Progression 13%
  • Cell Death 13%
  14 Citationer (Scopus)

  8 Downloads (Pure)

• The T-win® technology: immune-modulating vaccines

  Andersen, M. H., 11 jan. 2019, I: Seminars in Immunopathology. 41, 1, s. 87-95 9 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Vaccines 100%
  • Technology 87%
  • Indoleamine-Pyrrole 2,3,-Dioxygenase 60%
  • Tumor Microenvironment 46%
  • Vaccination 35%
  11 Citationer (Scopus)
• 2018

  Durable clinical responses and long-term follow-up of stage III-IV non-small-cell lung cancer (NSCLC) patients treated with IDO peptide vaccine in a phase i study-a brief research report

  Kjeldsen, J. W., Iversen, T. Z., Engell-Noerregaard, L., Mellemgaard, A., Andersen, M. H. & Svane, I. M., 2018, I: Frontiers in Immunology. 9, SEP, 6 s., 2145.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Indoleamine-Pyrrole 2,3,-Dioxygenase 100%
  • Subunit Vaccines 89%
  • Non-Small Cell Lung Carcinoma 66%
  • Vaccination 32%
  • Vaccines 18%
  16 Citationer (Scopus)

  32 Downloads (Pure)

• Frequent adaptive immune responses against arginase-1

  Martinenaite, E., Mortensen, R. E. J., Hansen, M., Orebo Holmström, M., Munir Ahmad, S., Grønne Dahlager Jørgensen, N., Met, Ö., Donia, M., Svane, I. M. & Andersen, M. H., 4 mar. 2018, I: OncoImmunology. 7, 3, 9 s., e1404215.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Arginase 100%
  • Adaptive Immunity 78%
  • T-Lymphocytes 21%
  • Peptide Library 16%
  • Myeloid-Derived Suppressor Cells 15%
  15 Citationer (Scopus)

• Immunoregulatory antigens-novel targets for cancer immunotherapy

  Pedersen, A. W., Kopp, K. L., Andersen, M. H. & Zocca, M-B., 1 apr. 2018, I: Chinese Clinical Oncology. 7, 2, s. 1-8 19.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Immunotherapy 100%
  • Neoplasm Antigens 80%
  • Antigens 72%
  • T-Lymphocytes 58%
  • Neoplasms 36%
  3 Citationer (Scopus)

• Interleukin-26 (IL-26) is a novel anti-microbial peptide produced by T cells in response to staphylococcal enterotoxin

  Woetmann, A., Alhede, M., Dabelsteen, S., Bjarnsholt, T., Rybtke, M., Nastasi, C., Krejsgaard, T., Andersen, M. H., Bonefeld, C. M., Geisler, C., Givskov, M. & Odum, N., 2018, I: OncoTarget. 9, 28, s. 19481-19489 9 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Enterotoxins 100%
  • Interleukins 87%
  • Staphylococcus aureus 55%
  • Peptides 51%
  • T-Lymphocytes 49%
  5 Citationer (Scopus)

  61 Downloads (Pure)

• Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies

  Klausen, U., Holmberg, S., Holmstrom, M. O., Jorgensen, N. G. D., Grauslund, J. H., Svane, I. M. & Andersen, M. H., 1 okt. 2018, I: Frontiers in Immunology. 9, 8 s., 2264.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Subunit Vaccines 100%
  • Hematologic Neoplasms 83%
  • Vaccination 52%
  • Antigens 52%
  • Tumor Microenvironment 51%
  13 Citationer (Scopus)

  54 Downloads (Pure)

• Sorted peripheral blood cells identify CALR mutations in B- and T-lymphocytes

  Kjaer, L., Holmström, M. O., Cordua, S., Andersen, M. H., Svane, I. M., Thomassen, M., Kruse, T. A., Pallisgaard, N., Skov, V. & Hasselbalch, H. C., 10 aug. 2018, I: Leukemia and Lymphoma. 59, 4, s. 973-977 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  9 Citationer (Scopus)

• Spontaneous T-cell responses against Arginase-1 in the chronic myeloproliferative neoplasms relative to disease stage and type of driver mutation

  Jørgensen, M. A., Holmström, M. O., Martinenaite, E., Riley, C. H., Hasselbalch, H. C. & Andersen, M. H., 2018, I: OncoImmunology. 7, 9, 8 s., e1468957.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Arginase 100%
  • T-Lymphocytes 47%
  • Mutation 42%
  • Neoplasms 24%
  • Peptides 13%
  8 Citationer (Scopus)

• Spontaneous T-cell responses against the immune check point programmed-death-ligand 1 (PD-L1) in patients with chronic myeloproliferative neoplasms correlate with disease stage and clinical response

  Holmström, M. O., Riley, C. H., Skov, V., Svane, I. M., Hasselbalch, H. C. & Andersen, M. H., 3 jun. 2018, I: OncoImmunology. 7, 6, e1433521.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Ligands 100%
  • T-Lymphocytes 87%
  • Neoplasms 45%
  • Epitopes 24%
  • Immunity 11%
  17 Citationer (Scopus)

• The balance players of the adaptive immune system

  Andersen, M. H., 2018, I: Cancer Research. 78, 6, s. 1379-1382

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Immune System 100%
  • T-Lymphocytes 78%
  • Tumor Microenvironment 52%
  • HLA Antigens 51%
  • Vaccination 40%
  14 Citationer (Scopus)

• The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

  Holmstrom, M. O., Martinenaite, E., Ahmad, S. M., Met, O., Friese, C., Kjaer, L., Riley, C. H., Straten, P. T., Svane, I. M., Hasselbalch, H. C. & Andersen, M. H., 1 feb. 2018, I: Leukemia. 32, 2, s. 429-437

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Calreticulin 100%
  • Exons 59%
  • T-Lymphocytes 44%
  • Mutation 40%
  • Neoplasms 23%
  47 Citationer (Scopus)

• The choriocarcinoma cell line JEG-3 upregulates regulatory T cell phenotypes and modulates pro-inflammatory cytokines through HLA-G

  Melsted, W. N., Matzen, S. H., Andersen, M. H. & Hviid, T. V. F., feb. 2018, I: Cellular Immunology. 324, s. 14-23

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • HLA-G Antigens 100%
  • Choriocarcinoma 85%
  • Regulatory T-Lymphocytes 67%
  • Up-Regulation 48%
  • Cytokines 42%
  5 Citationer (Scopus)

• The inhibitory checkpoint, PD-L2, is a target for effector T cells: Novel possibilities for immune therapy

  Ahmad, S. M., Martinenaite, E., Holmström, M., Jørgensen, M. A., Met, Ö., Nastasi, C., Klausen, U., Donia, M., Pedersen, L. M., Munksgaard, L., Ødum, N., Woetmann, A., Svane, I. M. & Andersen, M. H., 1 feb. 2018, I: OncoImmunology. 7, 2, 10 s., e1390641.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • T-Lymphocytes 100%
  • Epitopes 46%
  • Neoplasms 28%
  • B7 Antigens 26%
  • Therapeutics 26%
  18 Citationer (Scopus)
• 2017

  Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling

  Donia, M., Harbst, K., van Buuren, M., Kvistborg, P., Lindberg, M. F., Andersen, R., Idorn, M., Munir Ahmad, S., Ellebæk, E., Mueller, A., Fagone, P., Nicoletti, F., Libra, M., Lauss, M., Hadrup, S. R., Schmidt, H., Andersen, M. H., Thor Straten, P., Nilsson, J. A., Schumacher, T. N., & 3 flereSeliger, B., Jönsson, G. & Svane, I. M., 1 sep. 2017, I: Cancer Research. 77, 17, s. 4562-4566 5 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Antigens 100%
  • Immunotherapy 51%
  • Neoplasms 50%
  • Recurrence 45%
  • Antigen Presentation 42%
  27 Citationer (Scopus)

• Anti-regulatory T cells

  Andersen, M. H., 1 apr. 2017, I: Seminars in Immunopathology. 39, 3, s. 317–326 10 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Regulatory T-Lymphocytes 100%
  • Homeostasis 18%
  • Dioxygenases 18%
  • Indoleamine-Pyrrole 2,3,-Dioxygenase 17%
  • T-Lymphocytes 15%
  23 Citationer (Scopus)

• Butyrate and propionate inhibit antigen-specific CD8⁺ T cell activation by suppressing IL-12 production by antigen-presenting cells

  Nastasi, C., Fredholm, S., Willerslev-Olsen, A., Hansen, M., Bonefeld, C. M., Geisler, C., Andersen, M. H., Ødum, N. & Woetmann, A., dec. 2017, I: Scientific Reports. 7, 10 s., 14516.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • CD8 Antigens 100%
  • Propionates 94%
  • Butyrates 91%
  • Antigen-Presenting Cells 76%
  • Interleukin-12 74%
  25 Citationer (Scopus)

  95 Downloads (Pure)

• Cancer and autoimmunity

  Andersen, M. H., apr. 2017, I: Seminars in Immunopathology. 39, 3, s. 241-243 3 s.

  Publikation: Bidrag til tidsskrift › Leder › peer review

  3 Citationer (Scopus)

• Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma

  Nitschke, N. J., Bjoern, J., Iversen, T. Z., Andersen, M. H. & Svane, I. M., 1 sep. 2017, I: Stem Cell Investigation. 4, 13 s., 77.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Indoleamine-Pyrrole 2,3,-Dioxygenase 100%
  • Temozolomide 91%
  • Subunit Vaccines 89%
  • Survivin 88%
  • Melanoma 61%
  11 Citationer (Scopus)

• Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs

  Overgaard, N. H., Frøsig, T. M., Jakobsen, J. T., Buus, S., Andersen, M. H. & Jungersen, G., 9 okt. 2017, I: Vaccine. 35, 42, s. 5629-5636 8 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Miniature Swine 100%
  • adjuvants 78%
  • immunization 73%
  • T-lymphocytes 67%
  • Immunization 62%
  5 Citationer (Scopus)

  88 Downloads (Pure)

• Mikromiljøet som med- og modspiller i B-celle-non-Hodgkin-lymfomer

  Klausen, U., Andersen, M. H. & Pedersen, L. M., 2017, I: Ugeskrift for Læger. 179, 5 s., V03170220.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

• The JAK2V617F and CALR exon 9 mutations are shared immunogenic neoantigens in hematological malignancy

  Holmstrom, M. O., Hasselbalch, H. C. & Andersen, M. H., 2 nov. 2017, I: OncoImmunology. 6, 11, 3 s., e1358334.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Hematologic Neoplasms 100%
  • Exons 82%
  • Mutation 55%
  • Neoplasms 21%
  • Antigens 20%
  4 Citationer (Scopus)

• The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

  Holmström, M. O., Hjortso, M. D., Ahmad, S. M., Met, O., Martinenaite, E., Riley, C., Straten, P., Svane, I. M., Hasselbalch, H. C. & Andersen, M. H., 1 feb. 2017, I: Leukemia. 31, s. 495-498

  Publikation: Bidrag til tidsskrift › Letter › peer review

  30 Citationer (Scopus)

• The role of dendritic cells in cancer

  Hansen, M. & Andersen, M. H., 1 apr. 2017, I: Seminars in Immunopathology. 39, 3, s. 307-316

  Publikation: Bidrag til tidsskrift › Review › peer review

  • Dendritic Cells 100%
  • Neoplasms 36%
  • T-Lymphocytes 25%
  • Cross-Priming 19%
  • Catenins 17%
  37 Citationer (Scopus)
• 2016

  Anti-regulatory T cells

  Andersen, M. H., 2016, Københavns Universitet.

  Publikation: Bog/antologi/afhandling/rapport › Doktordisputats

• Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21

  Hansen, M., Met, Ö., Larsen, N. B., Rosenkilde, M. M., Andersen, M. H., Svane, I. M. & Hjorto, G. M., 1 sep. 2016, I: Cytotherapy. 18, 9, s. 1187-1196

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Dendritic Cells 100%
  • Cell Movement 91%
  • Dinoprostone 22%
  • Chemotaxis 18%
  • In Vitro Techniques 10%
  9 Citationer (Scopus)

• CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

  Martinenaite, E., Munir Ahmad, S., Hansen, M., Met, Ö., Westergaard, M. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, I. M. & Andersen, M. H., 2016, I: OncoImmunology. 5, 11, 10 s., e1238541.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Tumor Microenvironment 100%
  • Immunosuppressive Agents 80%
  • T-Lymphocytes 59%
  • Neoplasms 31%
  • T-Lymphocyte Epitopes 29%
  29 Citationer (Scopus)

• GTn repeat polymorphism in heme oxygenase-1 (HO-1) correlates with clinical outcome after myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation

  Køllgaard, T., Kornblit, B., Petersen, J., Klausen, T. W., Mortensen, B. K., Brændstrup, P., Sengeløv, H., Høgdall, E., Müller, K., Vindeløv, L., Andersen, M. H. & thor Straten, E. P., dec. 2016, I: PLoS ONE. 11, 12, 8 s., e0168210.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Oxygenases 100%
  • cell transplantation 70%
  • Transplantation 68%
  • heme oxygenase (biliverdin-producing) 68%
  • transplantation 61%
  5 Citationer (Scopus)

  54 Downloads (Pure)

• Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen

  Andersen, R., Donia, M., Ellebæk, E., Borch, T. H., Kongsted, P., Iversen, T. Z., Hølmich, L. R., Hendel, H. W., Met, Ö., Andersen, M. H., Thor Straten, E. P. & Svane, I. M., 1 aug. 2016, I: Clinical Cancer Research. 22, 15, s. 3734-3745 12 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Tumor-Infiltrating Lymphocytes 100%
  • Cell- and Tissue-Based Therapy 74%
  • Interleukin-2 70%
  • Melanoma 65%
  • Adoptive Transfer 38%
  128 Citationer (Scopus)

• mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma

  Borch, T. H., Engell-Noerregaard, L., Iversen, T. Z., Ellebaek, E., Met, Ö., Hansen, M., Andersen, M. H., thor Straten, E. P. & Svane, I. M., 1 sep. 2016, I: OncoImmunology. 5, 9, 12 s., e1207842.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Combined Vaccines 100%
  • Cyclophosphamide 68%
  • Dendritic Cells 65%
  • Melanoma 61%
  • Messenger RNA 41%
  20 Citationer (Scopus)

• Novel understanding of self-reactive T cells

  Andersen, M. H., mar. 2016, I: OncoImmunology. 5, 3, 2 s., e1083672 .

  Publikation: Bidrag til tidsskrift › Leder › peer review

  • T-Lymphocytes 100%
  • Immunity 44%
  • Clone Cells 42%
  2 Citationer (Scopus)

• PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine

  Munir Ahmad, S., Martinenaite, E., Hansen, M., Junker, N., Borch, T. H., Met, Ö., Donia, M., Svane, I. M. & Andersen, M. H., 2 aug. 2016, I: OncoImmunology. 5, 8, e1202391.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Cancer Vaccines 100%
  • Dendritic Cells 73%
  • Epitopes 70%
  • Vaccines 53%
  • Peptides 52%
  21 Citationer (Scopus)

• PD-L1-specific T cells

  Ahmad, S. M., Borch, T. H., Hansen, M. & Andersen, M. H., jul. 2016, I: Cancer Immunology, Immunotherapy. 65, 7, s. 797-804 8 s.

  Publikation: Bidrag til tidsskrift › Review › peer review

  • T-Lymphocytes 100%
  • T-Lymphocyte Epitopes 48%
  • Tumor Microenvironment 42%
  • Immunotherapy 35%
  • Vaccination 32%
  12 Citationer (Scopus)

• Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

  Jørgensen, N. G., Ahmad, S. M., Abildgaard, N., Straten, P. T., Svane, I. M., Andersen, M. H. & Knudsen, L. M., 2016, I: Stem Cell Investigation. 3, 5 s., 95.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Apoptosis Regulatory Proteins 100%
  • Multiple Myeloma 83%
  • Vaccination 67%
  • Peptides 53%
  • B-Cell Lymphoma 49%
  6 Citationer (Scopus)

• Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab

  Bjørn, J., Iversen, T. Z., Nitschke, N. J., Andersen, M. H. & Svane, I. M., 1 aug. 2016, I: Cytotherapy. 18, 8, s. 1043-1055 13 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Ipilimumab 100%
  • Indoleamine-Pyrrole 2,3,-Dioxygenase 96%
  • Melanoma 59%
  • Peptides 45%
  • Safety 41%
  29 Citationer (Scopus)

• The CALR exon 9 mutations are shared neoantigens in patients with CALR mutant chronic myeloproliferative neoplasms

  Holmström, M. O., Riley, C. H., Svane, I. M., Hasselbalch, H. C. & Andersen, M. H., 1 dec. 2016, I: Leukemia. 30, 12, s. 2413-2416 14 s.

  Publikation: Bidrag til tidsskrift › Letter › peer review

  36 Citationer (Scopus)

• The Expression of IL-21 Is Promoted by MEKK4 in Malignant T Cells and Associated with Increased Progression Risk in Cutaneous T-Cell Lymphoma

  Fredholm, S., Litvinov, I. V., Mongan, N. P., Schiele, S., Willerslev-Olsen, A., Petersen, D. L., Krejsgaard, T., Sibbesen, N., Nastasi, C., Bonefeld, C. M., Persson, J. L., thor Straten, E. P., Andersen, M. H., Koralov, S. B., Wasik, M. M., Geisler, C., Sasseville, D., Andersen, A. W. & Ødum, N., 2016, I: Journal of Investigative Dermatology. 136, 4, s. 866-869 4 s.

  Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

  3 Citationer (Scopus)
• 2015

  Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4⁺ T- Cells, Which Dampen CD8⁺ T-cell Antitumor Reactivity

  Donia, M., Andersen, R., Kjeldsen, J. W., Fagone, P., Munir, S., Nicoletti, F., Andersen, M. H., Thor Straten, P. & Svane, I. M., 15 sep. 2015, I: Cancer Research. 75, 18, s. 3747-59 13 s.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Melanoma 100%
  • T-Lymphocytes 74%
  • Neoplasms 38%
  • Tumor-Infiltrating Lymphocytes 38%
  • Histocompatibility Antigens Class II 33%
  51 Citationer (Scopus)

• Establishing the pig as a large animal model for vaccine development against human cancer

  Overgaard, N. H., Frøsig, T. M., Welner, S., Rasmussen, M., Ilsøe, M., Sørensen, M. R., Andersen, M. H., Buus, S. & Jungersen, G., 2015, I: Frontiers in Genetics. 6, 12 s., 286.

  Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  • Human Development 100%
  • Swine 73%
  • Vaccines 69%
  • Animal Models 67%
  • Peptides 42%
  10 Citationer (Scopus)